B. Riley Wealth Advisors’s Nephros NEPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-13,585
Closed -$99K 1073
2020
Q3
$99K Sell
13,585
-621
-4% -$4.54K 0.01% 894
2020
Q2
$120K Sell
14,206
-222
-2% -$1.76K 0.01% 805
2020
Q1
$91K Buy
14,428
+174
+1% +$1.48K 0.01% 727
2019
Q4
$142K Sell
14,254
-11,878
-45% -$106K 0.01% 781
2019
Q3
$211K Buy
+26,132
New +$192K 0.02% 713

Other funds holding NEPH

B. Riley Wealth Advisors's NEPH Position: Q4 2020 in Review

B. Riley Wealth Advisors sold out of Nephros (NEPH) in Q4 2020, closing a stake of 13,585 shares — an estimated $99K sold.

B. Riley Wealth Advisors first reported a position in NEPH in Q3 2019 and held it in 5 quarters. The position peaked at $211K in Q3 2019. 16 funds tracked by Wall St. Rank hold NEPH as of Q4 2020.

  • B. Riley Wealth Advisors reported no remaining Nephros position as of Q4 2020 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 13,585 Nephros shares in Q4 2020, an estimated $99K.
  • B. Riley Wealth Advisors first reported a position in Nephros in Q3 2019 and held it in 5 quarters.
  • B. Riley Wealth Advisors's Nephros position peaked at $211K in Q3 2019.
  • 16 funds tracked by Wall St. Rank held Nephros as of Q4 2020.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.